1. Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice. (6th June 2016) Authors: Yang, G-X; Sun, Y; Tsuneyama, K; Zhang, W; Leung, P S C; He, X-S; Ansari, A A; Bowlus, C; Ridgway, W M; Gershwin, M E Journal: Clinical and experimental immunology Issue: Volume 185:Number 2(2016:Aug.) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunological potential of cytotoxic T lymphocyte antigen 4 immunoglobulin in murine autoimmune cholangitis. (15th May 2015) Authors: Tanaka, H; Yang, G-X; Tomiyama, T; Tsuneyama, K; Zhang, W; Leung, P S C; Coppel, R L; Joh, T; Nadler, S G; Ansari, A A; Bowlus, C; Gershwin, M E Journal: Clinical and experimental immunology Issue: Volume 180:Number 3(2015:Jun.) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗